• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧以依赖 HIF-1α的方式下调骨肉瘤细胞表面 MICA 的表达,而不增加可溶性 MICA。

Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.

机构信息

Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

出版信息

Int J Oncol. 2012 Dec;41(6):2005-12. doi: 10.3892/ijo.2012.1630. Epub 2012 Sep 18.

DOI:10.3892/ijo.2012.1630
PMID:22992985
Abstract

Tumor cells express NKG2D ligands on their cell surface, which are the ligands of the activating receptor, NKG2D, that is expressed on the surface of NK cells. The binding of NK cells to tumor cells through the interaction of NKG2D and its ligands induces the cytolysis of the tumor cells. In the present study, we investigated the effects of hypoxia on the expression of NKG2D ligands on the surface of human osteosarcoma cells using three cell lines. To produce hypoxic and normoxic conditions, the osteosarcoma cell lines were cultured under 1 and 20% O2 conditions, respectively. The osteosarcoma cells expressed NKG2D ligands such as MHC class I-related chain molecules A and B (MICA and MICB) and the UL16-binding proteins 1, 2 and 3 (ULBP 1, 2 and 3). MICA was the most frequently expressed NKG2D ligand in the osteosarcoma cells. Hypoxia decreased the expression of cell surface MICA only without increasing the secretion of soluble MICA, which is produced by proteolytic cleavage of cell surface MICA. Hypoxia consistently decreased the susceptibility of the osteosarcoma cells to the cytotoxicity of the NK cells. Hypoxia induced the expression of hypoxia-inducible factor-1α (HIF-1α), and knockdown of the expression of HIF-1α using small interfering RNA increased the expression of cell surface MICA and concomitantly increased the level of soluble MICA. Hypoxia decreased the production of nitric oxide (NO) metabolites (nitrite and nitrate), thus, indicating a decreasing effect on NO production. However, a NO donor, NOC18, decreased the expression of cell surface MICA without any apparent effects on the expression of HIF-1α under both hypoxic and normoxic conditions. The present results indicate that hypoxia downregulates the expression of cell surface MICA without increasing the level of soluble MICA in a HIF-1α-dependent manner and suggest that the effects of hypoxia are not linked to the hypoxia-induced reduction of NO production.

摘要

肿瘤细胞在其细胞表面表达 NKG2D 配体,这些配体是 NK 细胞表面表达的激活受体 NKG2D 的配体。NK 细胞通过 NKG2D 与其配体的相互作用与肿瘤细胞结合,诱导肿瘤细胞的细胞溶解。在本研究中,我们使用三种细胞系研究了缺氧对人骨肉瘤细胞表面 NKG2D 配体表达的影响。为了产生缺氧和常氧条件,将骨肉瘤细胞系分别在 1%和 20%O2 条件下培养。骨肉瘤细胞表达 NKG2D 配体,如 MHC Ⅰ类相关链分子 A 和 B(MICA 和 MICB)和 UL16 结合蛋白 1、2 和 3(ULBP 1、2 和 3)。MICA 是骨肉瘤细胞中表达最频繁的 NKG2D 配体。缺氧仅降低细胞表面 MICA 的表达,而不增加通过细胞表面 MICA 的蛋白水解裂解产生的可溶性 MICA 的分泌。缺氧一致降低了骨肉瘤细胞对 NK 细胞细胞毒性的敏感性。缺氧诱导缺氧诱导因子-1α(HIF-1α)的表达,并用小干扰 RNA 敲低 HIF-1α 的表达增加了细胞表面 MICA 的表达,并同时增加了可溶性 MICA 的水平。缺氧减少了一氧化氮(NO)代谢物(亚硝酸盐和硝酸盐)的产生,因此表明对 NO 产生的抑制作用。然而,NO 供体 NOC18 在缺氧和常氧条件下均降低了细胞表面 MICA 的表达,而对 HIF-1α 的表达没有任何明显影响。本研究结果表明,缺氧以 HIF-1α 依赖的方式下调细胞表面 MICA 的表达,而不增加可溶性 MICA 的水平,并表明缺氧的作用与缺氧诱导的 NO 产生减少无关。

相似文献

1
Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.缺氧以依赖 HIF-1α的方式下调骨肉瘤细胞表面 MICA 的表达,而不增加可溶性 MICA。
Int J Oncol. 2012 Dec;41(6):2005-12. doi: 10.3892/ijo.2012.1630. Epub 2012 Sep 18.
2
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.可溶性ULBP通过下调NKG2D表达来抑制自然杀伤细胞活性。
Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21.
3
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析
Cancer Res. 2002 Nov 1;62(21):6178-86.
4
Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.丙戊酸钠,一种组蛋白去乙酰化酶抑制剂,可增强细胞表面 NKG2D 配体 MICA/B 的表达,而不增加其可溶性形式,从而增强人骨肉瘤细胞对 NK 细胞介导的细胞毒性的敏感性。
Oncol Rep. 2010 Dec;24(6):1621-7. doi: 10.3892/or_00001026.
5
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.作为人类神经母细胞瘤免疫逃逸策略的NKG2D配体下调和/或释放
Neoplasia. 2004 Sep-Oct;6(5):558-68. doi: 10.1593/neo.04316.
6
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.肼屈嗪和丙戊酸上调 NKG2D 配体并增强自然杀伤细胞的细胞毒性。
Int J Oncol. 2011 Dec;39(6):1491-9. doi: 10.3892/ijo.2011.1144. Epub 2011 Jul 26.
7
HIF-1alpha accumulation upregulates MICA and MICB expression on human cardiomyocytes and enhances NK cell cytotoxicity during hypoxia-reoxygenation.低氧复氧时 HIF-1alpha 积聚上调人心肌细胞上的 MICA 和 MICB 的表达并增强 NK 细胞的细胞毒性。
Life Sci. 2010 Jul 17;87(3-4):111-9. doi: 10.1016/j.lfs.2010.05.012. Epub 2010 May 27.
8
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.可溶性 NKG2D 受体配体在 HIV-1 感染过程中释放,并损害 NK 细胞的 NKG2D 表达和细胞毒性。
FASEB J. 2013 Jun;27(6):2440-50. doi: 10.1096/fj.12-223057. Epub 2013 Feb 8.
9
2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.2-脱氧-D-葡萄糖通过抑制 N 连接糖基化防止 NKG2D 配体的细胞表面表达。
J Immunol. 2012 Feb 15;188(4):1847-55. doi: 10.4049/jimmunol.1004085. Epub 2012 Jan 6.
10
Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.可溶性 NKG2D 配体的产生:蛋白水解切割、外泌体分泌及其功能意义。
Scand J Immunol. 2013 Aug;78(2):120-9. doi: 10.1111/sji.12072.

引用本文的文献

1
HIF-1α: A Key Factor Mediating Tumor Cells from Digestive System to Evade NK Cell Killing via Activating Metalloproteinases to Hydrolyze MICA/B.缺氧诱导因子-1α:介导消化系统肿瘤细胞通过激活金属蛋白酶水解MICA/B以逃避自然杀伤细胞杀伤的关键因子
Biomolecules. 2025 Jun 19;15(6):899. doi: 10.3390/biom15060899.
2
Tumor hypoxia shapes natural killer cell anticancer activities.肿瘤缺氧塑造自然杀伤细胞的抗癌活性。
J Mol Med (Berl). 2025 May 30. doi: 10.1007/s00109-025-02557-6.
3
Natural killer cells: the immune frontline against circulating tumor cells.
自然杀伤细胞:抵御循环肿瘤细胞的免疫前线。
J Exp Clin Cancer Res. 2025 Apr 10;44(1):118. doi: 10.1186/s13046-025-03375-x.
4
Adaptation of Natural Killer Cells to Hypoxia: A Review of the Transcriptional, Translational, and Metabolic Processes.自然杀伤细胞对缺氧的适应性:转录、翻译及代谢过程综述
Immunotargets Ther. 2025 Feb 18;14:99-121. doi: 10.2147/ITT.S492334. eCollection 2025.
5
Hypoxic tumor microenvironment: Destroyer of natural killer cell function.缺氧肿瘤微环境:自然杀伤细胞功能的破坏者。
Chin J Cancer Res. 2024 Apr 30;36(2):138-150. doi: 10.21147/j.issn.1000-9604.2024.02.04.
6
Alleviating hypoxia to improve cancer immunotherapy.缓解缺氧以改善癌症免疫疗法。
Oncogene. 2023 Dec;42(49):3591-3604. doi: 10.1038/s41388-023-02869-2. Epub 2023 Oct 26.
7
Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics.解决基于细胞的癌症治疗中自然杀伤细胞功能障碍和可塑性问题。
Cancers (Basel). 2023 Mar 13;15(6):1743. doi: 10.3390/cancers15061743.
8
Overcoming tumor resistance mechanisms in CAR-NK cell therapy.克服 CAR-NK 细胞治疗中的肿瘤耐药机制。
Front Immunol. 2022 Aug 3;13:953849. doi: 10.3389/fimmu.2022.953849. eCollection 2022.
9
The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?靶向缺氧改善癌症免疫治疗的前景:是虚幻还是现实?
Front Immunol. 2022 Jun 20;13:880810. doi: 10.3389/fimmu.2022.880810. eCollection 2022.
10
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.NKG2D应激配体的调控及其在癌症进展中的相关性
Cancers (Basel). 2022 May 9;14(9):2339. doi: 10.3390/cancers14092339.